Skip to main content
. Author manuscript; available in PMC: 2010 Mar 12.
Published in final edited form as: Am J Transplant. 2009 Jul 16;9(9):2126–2135. doi: 10.1111/j.1600-6143.2009.02738.x

Figure 2. Development of anti-HLA antibodies after transplant.

Figure 2

Serial serum samples from the four patients were tested for IgG reactive to a standard commercialized panel of cell lines expressing different HLA Class I and Class II antigens. Results are expressed as percentage of cell lines recognized by serum antibodies (left axis, panel reactive antibodies, PRA). The presence of donor-specific antibodies was assessed by a single HLA antigen bead Luminex assay using anti-HLA-DQ2 and -DR17 beads for Patient 4 and anti-HLA-DR53 beads for Patient 5. Signals are expressed as percentage of positive control (right axis).